• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-141/200c 的缺失通过重编程 NASH 中的多种信号通路改善肝脂肪变性和炎症。

Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.

机构信息

Department of Physiology and Neurobiology, and the Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut, USA.

Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.

出版信息

JCI Insight. 2017 Nov 2;2(21):96094. doi: 10.1172/jci.insight.96094.

DOI:10.1172/jci.insight.96094
PMID:29093267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752284/
Abstract

Accumulation of lipid droplets and inflammatory cell infiltration is the hallmark of nonalcoholic steatohepatitis (NASH). The roles of noncoding RNAs in NASH are less known. We aim to elucidate the function of miR-141/200c in diet-induced NASH. WT and miR-141/200c-/- mice were fed a methionine and choline deficient (MCD) diet for 2 weeks to assess markers of steatosis, liver injury, and inflammation. Hepatic miR-141 and miR-200c RNA levels were highly induced in human patients with NASH fatty liver and in WT MCD mice. miR-141/200c-/- MCD mice had reduced liver weights and triglyceride (TG) levels, which was associated with increased microsomal TG transfer protein (MTTP) and PPARα but reduced SREBP1c and FAS expression. Inflammation was attenuated and F4/80 macrophage activation was suppressed in miR-141/200c-/- mice, as evidenced by decreased serum aminotransferases and IL-6 and reduced hepatic proinflammatory, neutrophil, and profibrotic genes. Treatment with LPS in BM-derived macrophages isolated from miR-200c/141-/- mice polarized macrophages toward the M2 antiinflammatory state by increasing Arg1 and IL-10 levels while decreasing the M1 marker iNOS. In addition, elevated phosphorylated AMPK (p-AMPK), p-AKT, and p-GSK3β and diminished TLR4 and p-mTOR/p-4EBP1 proteins were observed. Lipidomics and metabolomics revealed alterations of TG and phosphatidylcholine (PC) lipid species by miR-141/200c deficiency. In summary, miR-141/200c deficiency diminished NASH-associated hepatic steatosis and inflammation by reprogramming lipid and inflammation signaling pathways.

摘要

脂滴积累和炎症细胞浸润是非酒精性脂肪性肝炎(NASH)的标志。非编码 RNA 在 NASH 中的作用知之甚少。我们旨在阐明 miR-141/200c 在饮食诱导的 NASH 中的作用。WT 和 miR-141/200c-/- 小鼠喂食蛋氨酸和胆碱缺乏(MCD)饮食 2 周,以评估脂肪变性、肝损伤和炎症的标志物。NASH 脂肪肝患者和 WT MCD 小鼠的肝 miR-141 和 miR-200c RNA 水平高度诱导。miR-141/200c-/- MCD 小鼠的肝重和甘油三酯(TG)水平降低,这与微粒体 TG 转移蛋白(MTTP)和 PPARα 增加但 SREBP1c 和 FAS 表达减少有关。miR-141/200c-/- 小鼠的炎症减轻,F4/80 巨噬细胞活化受到抑制,这表现在血清转氨酶和 IL-6 降低,肝前炎症、中性粒细胞和促纤维化基因减少。用 LPS 处理从 miR-200c/141-/- 小鼠分离的 BM 来源的巨噬细胞,通过增加 Arg1 和 IL-10 水平同时降低 M1 标志物 iNOS,将巨噬细胞极化到 M2 抗炎状态。此外,还观察到升高的磷酸化 AMPK(p-AMPK)、p-AKT 和 p-GSK3β 以及降低的 TLR4 和 p-mTOR/p-4EBP1 蛋白。脂质组学和代谢组学显示 miR-141/200c 缺乏导致 TG 和磷脂酰胆碱(PC)脂质种类发生变化。总之,miR-141/200c 缺乏通过重新编程脂质和炎症信号通路,减少与 NASH 相关的肝脂肪变性和炎症。

相似文献

1
Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.miR-141/200c 的缺失通过重编程 NASH 中的多种信号通路改善肝脂肪变性和炎症。
JCI Insight. 2017 Nov 2;2(21):96094. doi: 10.1172/jci.insight.96094.
2
Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.纤维蛋白原样蛋白 2 通过与 TLR4 相互作用加剧非酒精性脂肪性肝炎,在巨噬细胞中引发炎症,并诱导肝脂质代谢紊乱。
Theranostics. 2020 Aug 1;10(21):9702-9720. doi: 10.7150/thno.44297. eCollection 2020.
3
Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.胰高血糖素样肽-1类似物可预防非肥胖小鼠的非酒精性脂肪性肝炎。
World J Gastroenterol. 2016 Feb 28;22(8):2512-23. doi: 10.3748/wjg.v22.i8.2512.
4
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
5
Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.类格列汀抑制炎症性巨噬细胞激活,减轻非酒精性脂肪性肝炎和肝纤维化模型中的炎症、纤维化、氧化应激和血管功能障碍。
Antioxid Redox Signal. 2018 Jan 10;28(2):87-109. doi: 10.1089/ars.2016.6953. Epub 2017 Jul 25.
6
Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.肝脏特异性缺失 perilipin 2 可减轻饮食诱导的肝脂肪变性、炎症和纤维化。
Am J Physiol Gastrointest Liver Physiol. 2016 May 1;310(9):G726-38. doi: 10.1152/ajpgi.00436.2015. Epub 2016 Mar 11.
7
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).富含脂肪的巨噬细胞调节非酒精性脂肪性肝炎(NASH)中的小叶炎症。
Exp Mol Pathol. 2015 Aug;99(1):155-62. doi: 10.1016/j.yexmp.2015.06.015. Epub 2015 Jun 22.
8
Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.靶向精氨酸酶-II通过抑制巨噬细胞炎症反应保护小鼠免受高脂饮食诱导的肝脂肪变性。
Sci Rep. 2016 Feb 5;6:20405. doi: 10.1038/srep20405.
9
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.过氧化物酶体增殖物激活受体-α激动剂 Wy 14,643 可改善非酒精性脂肪性肝炎糖尿病小鼠的代谢指标、脂肪变性和气球样变。
J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.
10
Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.丙酮酸脱氢酶激酶4介导脂肪生成并促进非酒精性脂肪性肝炎的发病机制。
Biochem Biophys Res Commun. 2018 Jan 1;495(1):582-586. doi: 10.1016/j.bbrc.2017.11.054. Epub 2017 Nov 9.

引用本文的文献

1
mTOR Signaling in Macrophages: All Depends on the Context.巨噬细胞中的mTOR信号传导:一切取决于具体情况。
Int J Mol Sci. 2025 Aug 6;26(15):7598. doi: 10.3390/ijms26157598.
2
The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD.循环微小RNA在非酒精性脂肪性肝病的诊断、预后及个性化治疗中的应用
J Physiol Biochem. 2025 Jul 16. doi: 10.1007/s13105-025-01110-w.
3
The power of microRNA regulation-insights into immunity and metabolism.微小RNA调控的力量——对免疫和代谢的见解
FEBS Lett. 2025 Jul;599(13):1821-1851. doi: 10.1002/1873-3468.70039. Epub 2025 Apr 11.
4
miR-200c inhibition and catalase accelerate diabetic wound healing.miR-200c抑制与过氧化氢酶可加速糖尿病伤口愈合。
J Biomed Sci. 2025 Feb 14;32(1):21. doi: 10.1186/s12929-024-01113-7.
5
Elevated mir-141 in obesity: Insights into the interplay with sirtuin 1 and non-alcoholic fatty liver disease.肥胖中升高的mir-141:对其与沉默调节蛋白1及非酒精性脂肪性肝病相互作用的见解
Obes Sci Pract. 2024 Sep 27;10(5):e70007. doi: 10.1002/osp4.70007. eCollection 2024 Oct.
6
MicroRNA-mediated metabolic regulation of immune cells in cancer: an updated review.微小 RNA 介导的癌症免疫细胞代谢调控:最新综述。
Front Immunol. 2024 Jun 28;15:1424909. doi: 10.3389/fimmu.2024.1424909. eCollection 2024.
7
Hepatocyte miR-21-5p-deficiency alleviates APAP-induced liver injury by inducing PPARγ and autophagy.肝细胞 miR-21-5p 缺失通过诱导 PPARγ 和自噬缓解对乙酰氨基酚诱导的肝损伤。
Toxicol Sci. 2024 Feb 28;198(1):50-60. doi: 10.1093/toxsci/kfad132.
8
Exercise-mediated macrophage polarization modulates the targeted therapeutic effect of NAFLD: a review.运动介导的巨噬细胞极化调节非酒精性脂肪性肝病的靶向治疗效果:综述
Phys Act Nutr. 2023 Sep;27(3):10-16. doi: 10.20463/pan.2023.0023. Epub 2023 Sep 30.
9
Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice.使用C57BL/6小鼠的非酒精性脂肪性肝炎新型小鼠模型中肝脏巨噬细胞亚群的动态变化
Biomedicines. 2023 Sep 28;11(10):2659. doi: 10.3390/biomedicines11102659.
10
MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis.微小 RNA:在巨噬细胞极化和肝纤维化发病机制中的作用。
Front Immunol. 2023 Apr 17;14:1147710. doi: 10.3389/fimmu.2023.1147710. eCollection 2023.

本文引用的文献

1
High-mobility-group protein 2 regulated by microRNA-127 and small heterodimer partner modulates pluripotency of mouse embryonic stem cells and liver tumor initiating cells.受微小RNA-127和小异二聚体伴侣调控的高迁移率族蛋白2调节小鼠胚胎干细胞和肝肿瘤起始细胞的多能性。
Hepatol Commun. 2017 Oct;1(8):816-830. doi: 10.1002/hep4.1086. Epub 2017 Aug 28.
2
LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis.长链非编码RNA AK054921和AK128652是酒精性肝硬化患者生存的潜在血清生物标志物和预测指标。
Hepatol Commun. 2017 Aug;1(6):513-523. doi: 10.1002/hep4.1061. Epub 2017 Aug 2.
3
H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.H19 通过阻止 ZEB1 介导的上皮细胞粘附分子抑制来促进胆汁淤积性肝纤维化。
Hepatology. 2017 Oct;66(4):1183-1196. doi: 10.1002/hep.29209. Epub 2017 Aug 26.
4
The microRNA-200 family: still much to discover.微小RNA-200家族:仍有许多有待发现之处。
Biomol Concepts. 2016 Dec 1;7(5-6):311-319. doi: 10.1515/bmc-2016-0020.
5
Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge and Shp Deficiency.代谢组学分析揭示了慢性乙醇加暴饮和Shp缺乏所改变的代谢物的独特周期性变化。
Alcohol Clin Exp Res. 2016 Dec;40(12):2548-2556. doi: 10.1111/acer.13257. Epub 2016 Oct 28.
6
Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.长链非编码RNA MEG3通过与PTBP1相互作用促进shp mRNA降解,从而诱导胆汁淤积性肝损伤。
Hepatology. 2017 Feb;65(2):604-615. doi: 10.1002/hep.28882. Epub 2016 Dec 24.
7
REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver.视黄酸受体相关孤儿受体α激活C/EBP同源蛋白以控制小异源二聚体伴侣介导的酒精性脂肪肝振荡。
Am J Pathol. 2016 Nov;186(11):2909-2920. doi: 10.1016/j.ajpath.2016.07.014. Epub 2016 Sep 21.
8
Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.作为第二信使分子的鞘磷脂-神经酰胺-糖鞘脂途径的化合物:脂肪肝疾病和胰岛素抵抗新疗法的新靶点。
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1102-17. doi: 10.1152/ajpgi.00095.2016. Epub 2016 May 12.
9
Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.miR-200b和miR-200c表达降低通过刺激JUN表达和激活srebp1转录导致肝脏脂质异常蓄积。
Oncotarget. 2016 Jun 14;7(24):36207-36219. doi: 10.18632/oncotarget.9183.
10
Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis.非酒精性脂肪性肝炎发生发展中的新型分子机制
Diabetes Metab J. 2016 Feb;40(1):1-11. doi: 10.4093/dmj.2016.40.1.1.